UPC Analytics
DEEN
Übersicht · Eingereicht: 11. Juli 2024

UPC_CoA_405/2024

TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT

BerufungenHauptberufungCourt of AppealAppealCase Closed
  • 2024-12-20PI abgelehntAppeal RoP220.1

    The Court of Appeal dismissed Alexion's appeal against the first-instance refusal of provisional measures, upholding the finding that the patent claim could not be corrected by interpretation to remove alleged errors, and confirming that claim 2 of EP 3 167 888 was more likely than not insufficiently disclosed (Article 83 EPC). The provisional measures application was therefore denied.